Close

UBS Maintains a 'Neutral' on Momenta Pharmaceuticals (MNTA); Adjusting PT for Increased Macro Concerns

Go back to UBS Maintains a 'Neutral' on Momenta Pharmaceuticals (MNTA); Adjusting PT for Increased Macro Concerns